Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group.
about
The impact of neuropsychological functioning on adherence to HAART in HIV-infected substance abuse patientsNo evidence of increased sexual risk behaviour after initiating antiretroviral therapy among people who inject drugs.Substance abuse, adherence with antiretroviral therapy, and clinical outcomes among HIV-infected individuals.Care at the Crossroads: Navigating the HIV, HCV, and Substance Abuse Syndemic.Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users.Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach.Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overviewFactors associated with liver biopsy performance in HCV-HIV coinfected injecting drug users with HCV viremia: results from a five-year longitudinal assessment.Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations.Antiretroviral use among active injection-drug users: the role of patient-provider engagement and structural factors.Neurocognitive impact of antiretroviral treatment: thinking long-term.The paradigm of universal access to HIV-treatment and human rights violation: how do we treat HIV-positive people who use drugs?HIV-infected individuals who use alcohol and other drugs, and virologic suppression.Drug treatment and the conditionality of HIV treatment access: a qualitative study in a Russian city.Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use.Methadone maintenance therapy and HIV counseling and testing are associated with lower frequency of risky behaviors among injection drug users in China.Role of substance use in HIV care cascade outcomes among people who inject drugs in Russia.Access to antiretroviral therapy among HIV/AIDS patients in Khon Kaen Province, Thailand.Oral contraception and unprotected sex with occasional partners of women HIV-infected through injection drug use.Hospitalization for depressive syndrome in a cohort of HIV-infected patients contaminated through injecting drug use: MANIF 2000 cohort, France, 1995-1999
P2860
Q33797580-54289493-6737-45B7-90FC-985820593C50Q34091151-3874FC50-AC47-4DE0-867F-646A4BE35A5BQ34524937-CEC764DC-394B-421F-B819-B1E7FBFE4DFBQ34702334-06D77C25-6C49-4036-93D8-DEEED8A7FF26Q35407959-C266F305-49E0-4068-B571-7735A6CC6695Q35777089-0530F371-3D79-4F7E-81C6-E76D5CF0FA10Q36063045-BD916C67-9BD8-48D4-BA88-4AE9C16C8D13Q36273083-6E053E78-CAC6-49EF-B879-C931889398C3Q36742039-10514373-3878-4FAA-9571-3C48561BD6CAQ37550334-D5DA37BD-5EFC-4399-A030-B451658F43A2Q37916327-1574F40B-FC3A-4C7F-A660-3C3136C6D21EQ38173892-5ED124AD-DC1B-40B1-9ED1-39470DFCA83CQ38781165-B019D0E4-1A66-4456-926A-446C40C8F48CQ39395694-843DB50B-1A4B-4F15-A47E-25760B66C1FFQ39763489-B832E064-828F-46B3-BF0E-BD3A80F319ECQ41711312-1AA70B42-40BA-4203-951C-FCB59BB089CFQ47110571-CFC7FABF-F0D9-4B27-9DE1-EF5132A593A2Q50132784-6EC76712-EAE6-4401-89C2-2EFD897E4B6CQ51786436-207B7CE1-B0E8-4C9E-95E7-C8BD58669210Q58266382-574E847C-57B1-4DA0-B05C-B09F1BFEB695
P2860
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Access to antiretroviral treat ...... g use. MANIF 2000 Study Group.
@ast
Access to antiretroviral treat ...... g use. MANIF 2000 Study Group.
@en
type
label
Access to antiretroviral treat ...... g use. MANIF 2000 Study Group.
@ast
Access to antiretroviral treat ...... g use. MANIF 2000 Study Group.
@en
prefLabel
Access to antiretroviral treat ...... g use. MANIF 2000 Study Group.
@ast
Access to antiretroviral treat ...... g use. MANIF 2000 Study Group.
@en
P2093
P2860
P356
P1476
Access to antiretroviral treat ...... g use. MANIF 2000 Study Group.
@en
P2093
Carrieri MP
Reynaud-Maurupt C
P2860
P356
10.1136/JECH.53.1.4
P577
1999-01-01T00:00:00Z